Journal article icon

Journal article

Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study

Abstract:

Background Ten-valent pneumococcal conjugate vaccine (PCV10), delivered at 6, 10, and 14 weeks of age was introduced in Kenya in January, 2011, accompanied by a catch-up campaign in Kilifi County for children aged younger than 5 years. Coverage with at least two PCV10 doses in children aged 2–11 months was 80% in 2011 and 84% in 2016; coverage with at least one dose in children aged 12–59 months was 66% in 2011 and 87% in 2016. We aimed to assess PCV10 effect against nasop...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM
Role:
Author
Publisher:
Elsevier
Journal:
Lancet More from this journal
Volume:
393
Issue:
10186
Pages:
2146-2154
Publication date:
2019-04-15
Acceptance date:
2018-11-15
DOI:
EISSN:
1474-547X
ISSN:
0140-6736
Pmid:
31000194
Language:
English
Pubs id:
pubs:1004844
UUID:
uuid:f7ce8a4e-07a9-40fb-baef-6945c02c94a3
Local pid:
pubs:1004844
Source identifiers:
1004844
Deposit date:
2019-06-05

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP